Verve Therapeutics Inc (VERV)
6.42
+0.01
(+0.16%)
USD |
NASDAQ |
May 06, 16:00
6.415
0.00 (0.00%)
After-Hours: 20:00
Verve Therapeutics Stock Buybacks (Quarterly): -176.76M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -176.76M |
| September 30, 2023 | -31.78M |
| June 30, 2023 | 0.065M |
| March 31, 2023 | -1.987M |
| December 31, 2022 | -38.59M |
| September 30, 2022 | -287.90M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | -285.21M |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-287.90M
Minimum
Sep 2022
0.065M
Maximum
Jun 2023
-58.73M
Average
--
Median
Jun 2020
Stock Buybacks (Quarterly) Benchmarks
| Acorda Therapeutics Inc | -- |
| Eli Lilly and Co | 0.00 |
| Beam Therapeutics Inc | -33.60M |
| Intellia Therapeutics Inc | -103.61M |
| Gritstone Bio Inc | -5.488M |